COVID-19 and the liver: A brief and core review

doi:10.4254/wjh.v13.i12.2013

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3676)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

303

WORD

HTML

1791

Figures (1-1)

182

Sum=2327

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

448

Download

901

Sum=1349

Dec 27, 2021 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Dec 27, 2021; 13(12): 2013-2023
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2013

Open in New Tab Full Size Figure Download Figure

Figure 1 Possible mechanisms of liver injury in coronavirus disease 2019. ACE2: Angiotensin-converting enzyme 2; ARDS: Acute respiratory distress syndrome; NSAIDs: Non-steroidal anti-inflammatory drugs; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.

Citation: Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023
URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2013.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2013